Celsion
This article was originally published in The Gray Sheet
Executive Summary
Firm is gearing up to commence Phase I trials of its microwave treatment system for breast cancer following investigational device exemption clearance, announced Aug. 16. The trial will include ten patients to be treated at two sites. The device uses heat to destroy tumors in a "non toxic" manner, the firm explains (1"The Gray Sheet" Oct. 26, 1998, p. 19). Separately, Celsion is awaiting FDA sign-off to begin Phase II trials of its microwave benign prostatic hyperplasia treatment system. The company completed Phase I trials on ten patients earlier this year